Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127419951 | 12741995 | 1 | I | 20160907 | 20160914 | 20160914 | EXP | PHEH2016US022720 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127419951 | 12741995 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 400 MG, UNK | 21588 | 400 | MG | ||||||||
| 127419951 | 12741995 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 600 MG, UNK | 21588 | 600 | MG | ||||||||
| 127419951 | 12741995 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127419951 | 12741995 | 4 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127419951 | 12741995 | 5 | C | CALCIUM + VIT D | CALCIUMVITAMIN D | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127419951 | 12741995 | 1 | Product used for unknown indication |
| 127419951 | 12741995 | 3 | Product used for unknown indication |
| 127419951 | 12741995 | 4 | Product used for unknown indication |
| 127419951 | 12741995 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127419951 | 12741995 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127419951 | 12741995 | Alopecia | |
| 127419951 | 12741995 | Asthenia | |
| 127419951 | 12741995 | Bone pain | |
| 127419951 | 12741995 | Immunodeficiency | |
| 127419951 | 12741995 | Nausea | |
| 127419951 | 12741995 | Neoplasm recurrence | |
| 127419951 | 12741995 | Ocular hyperaemia | |
| 127419951 | 12741995 | Pain in extremity | |
| 127419951 | 12741995 | Peripheral swelling | |
| 127419951 | 12741995 | Skin discolouration | |
| 127419951 | 12741995 | Sleep disorder | |
| 127419951 | 12741995 | Vision blurred | |
| 127419951 | 12741995 | Vomiting | |
| 127419951 | 12741995 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |